Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MedinCell S.A (PA: MEDCL)

 
MEDCL Technical Analysis
5
As on 13th Oct 2025 MEDCL STOCK Price closed @ 33.22 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 15.68 & Strong Buy for SHORT-TERM with Stoploss of 14.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MEDCLSTOCK Price

Open 28.56 Change Price %
High 33.40 1 Day 5.78 21.06
Low 28.50 1 Week 7.46 28.96
Close 33.22 1 Month 16.09 93.93
Volume 591528 1 Year 18.32 122.95
52 Week High 28.64 | 52 Week Low 12.84
 
PA France Most Active Stocks
ALBOO 0.00 %
ALVER 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALRPD 0.00 %
CGG 0.69 -2.82%
ALNRG 0.00 %
ALHYG 0.01 0.00%
ALTBG 2.88 %
ALADO 0.00 %
 
PA France Top Gainers Stocks
MEDCL 33.22 21.06%
ALAGO 0.16 14.29%
NANO 24.45 9.15%
NANO 24.45 9.15%
NANO 24.45 9.15%
2MX 7.46 8.43%
ALCLS 3.90 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
ALGBE 0.02 -33.33%
FPN 0.02 -33.33%
PROAC 0.05 -16.67%
MLPRX 0.20 -16.67%
ALNEV 0.11 -15.38%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALROC 0.18 -10.00%
 
 
MEDCL
Daily Charts		 MEDCL
Intraday Charts		 Whats New @
Bazaartrend		 MEDCL
Free Analysis
 
MEDCL Important Levels Intraday
RESISTANCE42.66
RESISTANCE39.63
RESISTANCE37.76
RESISTANCE35.89
SUPPORT30.55
SUPPORT28.68
SUPPORT26.81
SUPPORT23.78
 
MEDCL Forecast October 2025
Share
4th UP Forecast40.85
3rd UP Forecast38.4
2nd UP Forecast36.89
1st UP Forecast35.38
1st DOWN Forecast31.06
2nd DOWN Forecast29.55
3rd DOWN Forecast28.04
4th DOWN Forecast25.59
 
MEDCL Weekly Forecast
4th UP Forecast37.07
3rd UP Forecast35.84
2nd UP Forecast35.07
1st UP Forecast34.31
1st DOWN Forecast32.13
2nd DOWN Forecast31.37
3rd DOWN Forecast30.60
4th DOWN Forecast29.37
 
MEDCL Forecast2025
4th UP Forecast74.46
3rd UP Forecast61.23
2nd UP Forecast53.06
1st UP Forecast44.88
1st DOWN Forecast21.56
2nd DOWN Forecast13.38
3rd DOWN Forecast5.21
4th DOWN Forecast-8.02
 
 
MEDCL Other Details
Segment EQ
Market Capital 251922896.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MEDCL Address
MEDCL
 
MEDCL Latest News
 
Your Comments and Response on MedinCell S.A
 
MEDCL Business Profile
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France. Address: 3 rue des Frères Lumière, Jacou, France, 34830
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service